SecSonar.com

Elutia Inc. (ELUT)

Elutia Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Elutia Inc. (ELUT) is a Biotechnology company based in US with a market capitalization of $49.7M. Revenue declined 49.6% year-over-year and free cash flow was negative at -$46.7M. This page tracks ELUT's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 51 employees · IPO Oct 8, 2020

Valuation

Valuation & price

$1.03 · as of May 17, 2026 · -58.1% vs 52w high

0.9

P/E ratio

Latest-FY diluted EPS

1.80

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$2.46$1.50$0.54Jul 25Dec 25Jul 26Jul 7, 25$2.08Jul 9, 25$2.46Jul 11, 25$2.39Jul 15, 25$1.98Jul 17, 25$2.03Jul 21, 25$2.13Jul 23, 25$2.04Jul 25, 25$1.92Jul 29, 25$1.84Jul 31, 25$2.03Aug 4, 25$1.99Aug 6, 25$1.97Aug 11, 25$1.97Aug 13, 25$2.16Aug 15, 25$2.02Aug 19, 25$2.02Aug 21, 25$2.20Aug 25, 25$2.39Aug 27, 25$2.21Aug 29, 25$2.28Sep 3, 25$1.99Sep 5, 25$1.88Sep 9, 25$1.48Sep 11, 25$1.31Sep 16, 25$1.18Sep 18, 25$1.08Sep 22, 25$1.11Sep 24, 25$1.05Sep 26, 25$0.99Sep 30, 25$0.89Oct 2, 25$0.90Oct 6, 25$0.88Oct 8, 25$0.89Oct 10, 25$0.89Oct 14, 25$0.89Oct 16, 25$0.90Oct 21, 25$0.90Oct 23, 25$0.91Oct 27, 25$0.90Oct 29, 25$0.90Oct 31, 25$0.91Nov 4, 25$0.92Nov 6, 25$0.94Nov 10, 25$0.86Nov 12, 25$0.74Nov 14, 25$0.75Nov 18, 25$0.70Nov 20, 25$0.61Nov 25, 25$0.62Nov 28, 25$0.61Dec 2, 25$0.65Dec 4, 25$0.69Dec 8, 25$0.68Dec 10, 25$0.70Dec 12, 25$0.70Dec 16, 25$0.55Dec 18, 25$0.54Dec 22, 25$0.55Dec 24, 25$0.56Dec 29, 25$0.54Jan 2, 26$0.64Jan 6, 26$0.63Jan 8, 26$0.69Jan 12, 26$0.69Jan 14, 26$0.84Jan 16, 26$0.82Jan 21, 26$0.92Jan 23, 26$0.95Jan 27, 26$1.00Jan 29, 26$1.05Feb 2, 26$1.02Feb 4, 26$0.99Feb 9, 26$0.95Feb 11, 26$0.90Feb 13, 26$1.05Feb 18, 26$1.20Feb 20, 26$1.08Feb 24, 26$1.09Feb 26, 26$1.15Mar 2, 26$1.14Mar 4, 26$1.19Mar 6, 26$1.09Mar 10, 26$1.09Mar 12, 26$1.15Mar 17, 26$1.09Mar 19, 26$1.05Mar 23, 26$1.11Mar 25, 26$1.12Mar 27, 26$1.07Mar 31, 26$1.05Apr 2, 26$1.17Apr 7, 26$1.16Apr 9, 26$1.13Apr 13, 26$1.10Apr 15, 26$1.17Apr 17, 26$1.15Apr 22, 26$1.15Apr 24, 26$1.07Apr 28, 26$1.00Apr 30, 26$1.02May 4, 26$1.01May 6, 26$1.02May 8, 26$1.01May 12, 26$1.05May 14, 26$1.04May 18, 26$1.10May 20, 26$1.18May 22, 26$1.16May 28, 26$1.12Jun 1, 26$1.06Jun 3, 26$0.99Jun 5, 26$1.00Jun 9, 26$0.97Jun 11, 26$0.96Jun 15, 26$0.97Jun 17, 26$0.99Jun 22, 26$1.00Jun 24, 26$0.98Jun 26, 26$1.00Jul 2, 26$0.93
$0.5152-week range$2.46
Loading valuation history…

Fundamentals

Key fundamentals

$49.7M

Market cap

-49.6%

Revenue growth (YoY)

53.7%

Gross margin

-$46.7M

Free cash flow (USD)

-$28.8M

Net debt

Net cash position

42.5%

Share dilution

1/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2018 → 2025

FY 2018$39.0MFY 2019$42.9MFY 2020$42.7MFY 2021$47.4MFY 2022$23.8MFY 2023$24.7MFY 2024$24.4MFY 2025$12.3M
$39M$12.3M

Free cash flow by year

2018 → 2025

FY 2018$-5.3MFY 2019$-7.8MFY 2020$-14.3MFY 2021$-15.8MFY 2022$-22.0MFY 2023$-22.1MFY 2024$-23.3MFY 2025$-46.7M
-$5.3M-$46.7M

Gross margin by year

2021 → 2025

FY 202140.1%FY 202248.8%FY 202344.7%FY 202443.9%FY 202553.7%
40.1%53.7%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last reported: May 14, 2026 (EPS $-0.17)

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventAnnual Meeting ResultsJun 16, 2026Filing
  • Quarterly report10-Q FiledMay 15, 2026Filing
  • 8-K eventEarnings ReleaseMay 14, 2026Filing

Questions

Frequently asked questions

What is Elutia Inc.'s market cap?

Elutia Inc. (ELUT) has a market capitalization of $49.7M.

What is ELUT's P/E ratio?

ELUT trades at a price-to-earnings ratio of 0.9, based on its latest fiscal-year diluted earnings per share and the most recent cached price.

What is ELUT's price-to-book (P/B) ratio?

ELUT trades at 1.80 times book value per share.

When did Elutia Inc. last report earnings?

ELUT last reported earnings on May 14, 2026; the next date is not yet scheduled.

Are insiders buying ELUT stock?

SEC Form 4 filings show no open-market insider buys at Elutia Inc. in the last 90 days (0 sells).

Same arena

Related companies in Biotechnology

XLO

Xilio Therapeutics, Inc.

$49.8M

GOSS

Gossamer Bio, Inc.

$49.4M

MGX

Metagenomi, Inc. Common Stock

$51.6M

ATYR

aTyr Pharma, Inc.

$53.9M

MREO

Mereo BioPharma Group plc

$55.5M

CUE

Cue Biopharma, Inc.

$57.5M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.